Oscar Health, Inc. (OSCR) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$19.84
Price Target
$16.75
Target Range
$15.00 — $18.00
Analyst Rating
Hold
Forward P/E32.9x
Trailing P/E-11.7x
Forward PEG—
Implied Growth+138.5%
Median Target$17.00
Analyst Spread17.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$15
-24.4%
Consensus
$17
-15.6%
Bull Case
$18
-9.3%
OSCR Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Oscar Health, Inc. (OSCR) has a Wall Street consensus price target of $16.75, based on estimates from 11 covering analysts. With the stock currently trading at $19.84, this represents a potential downside of -15.6%. The company has a market capitalization of $5.14B.
Analyst price targets range from a low of $15.00 to a high of $18.00, representing a 18% spread in expectations. The median target of $17.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, OSCR trades at a trailing P/E of -11.7x and forward P/E of 32.9x. Analysts expect EPS to grow +138.5% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+23.1%
Avg Forward P/E35.6x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CLOVClover Health Investments, Corp. | $1.4B | $2.68 | $3.33 | +24.3% | Hold | 62.6x | 9 |
 ALHCAlignment Healthcare, Inc. | $3.7B | $18.14 | $24.83 | +36.9% | Buy | 140.1x | 16 |
 ACGLArch Capital Group Ltd. | $33.7B | $94.70 | $104.00 | +9.8% | Buy | 10.1x | 34 |
 BHVNBiohaven Ltd. | $1.1B | $10.04 | $21.29 | +112.1% | Buy | — | 25 |
 MIRAMIRA Pharmaceuticals, Inc. | $40M | $1.00 | — | — | — | — | — |
 UNHUnitedHealth Group Incorporated | $333.4B | $367.28 | $385.43 | +4.9% | Buy | 20.1x | 52 |
 CVSCVS Health Corporation | $111.3B | $86.86 | $95.20 | +9.6% | Buy | 12.1x | 41 |
 CICigna Corporation | $74.3B | $281.98 | $328.00 | +16.3% | Buy | 9.3x | 39 |
 ELVElevance Health Inc. | $81.4B | $374.71 | $382.38 | +2.0% | Buy | 14.0x | 37 |
 CNCCentene Corporation | $27.3B | $55.31 | $51.00 | -7.8% | Buy | 16.4x | 43 |
Upside Potential Comparison
BHVNALHCCLOVCIACGLCVSUNHELVSee OSCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OSCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OSCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOSCR — Frequently Asked Questions
Quick answers to the most common questions about buying OSCR stock.
What is the OSCR stock price target for 2026?
OSCR's consensus price target is $16.75, -15.6% below the current price of $19.84. The 11 analysts tracking OSCR see downside risk at present valuations.
Is OSCR a buy, sell, or hold?
OSCR has a consensus rating of "Hold" based on 11 Wall Street analysts. The rating breakdown is mixed, with 7 Hold ratings making up the largest segment. The consensus 12-month price target of $16.75 implies -15.6% downside from current levels.
Is OSCR stock overvalued or undervalued?
OSCR trades at a forward P/E of 32.9404x, representing a moderate valuation. With analysts targeting $16.75 (-15.6% implied move), the stock appears close to fair value.
How high can OSCR stock go?
The most bullish Wall Street analyst has a price target of $18 for OSCR, while the most conservative target is $15. The consensus of $16.75 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover OSCR stock?
OSCR is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 7 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the OSCR stock forecast?
The 12-month OSCR stock forecast based on 11 Wall Street analysts shows a consensus price target of $16.75, with estimates ranging from $15 (bear case) to $18 (bull case). The median consensus rating is "Hold".
What is OSCR's forward P/E ratio?
OSCR trades at a forward P/E ratio of 32.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy OSCR stock?
Analysts are cautious on OSCR, with 2 Sell ratings and a price target of $16.75 (-15.6% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do OSCR price targets vary so much?
OSCR analyst price targets range from $15 to $18, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $16.75 consensus represents the middle ground.